Number of Shares
122.00
Current Holdings Value*
$38,860.00
% of Portfolio
1.15%
Total Estimate Gain
$12,724.03
% of Total Estimate Gain
15.86%

SERIES Z (ALPHA OPPORTUNITY SERIES)'s United Therapeutics Corp Holding Summary

As of 2024-06-30, Guggenheim Variable Funds Trust held 122.00 shares of United Therapeutics Corp(UTHR), totaling $38,860.00. This investment constitutes 1.15% of their stock portfolio, and Guggenheim Variable Funds Trust now holds 0% of the outstanding United Therapeutics Corp(UTHR) stock.

The initial trade took place in 2021Q4. And since then SERIES Z (ALPHA OPPORTUNITY SERIES) has made 4 purchases of UTHR, at an average price of $217.95, for a total of 368.00 shares. In addition, there have been 7 sales at an average price of $229.92 for 246.00 shares. Based on historical transaction data and UTHR's current price of $298.10, SERIES Z (ALPHA OPPORTUNITY SERIES)'s estimated gain on his UTHR holdings is $12,724.03, reflecting a 15.86% gain to date.

SERIES Z (ALPHA OPPORTUNITY SERIES) UTHR ($298.10) Holding Chart

SERIES Z (ALPHA OPPORTUNITY SERIES) UTHR ($298.10) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1